Reported the account's leftover balance as encumbered

The FY2024 report certifies 17,002.43 appropriated or encumbered but not yet spent in the reporting period 7/1/2023 to 6/30/2024 (p1). Account 4-02-40-754-201 opens at 20,173.03. It paid 120.00 on 05/07/2024, 2,499.00 on 06/11/2024 and 551.60 for Narcan on 09/10/2024. The running balance the audit trail prints after the 09/10/2024 Narcan check is 17,002.43, the certified figure to the cent. No order was open on the account at 06/30/2024. Both earlier orders were paid, the Narcan order was first encumbered 08/15/2024, and the next order, MJPB Consulting purchase order 24-03009 for 8,250.00, opened 10/25/2024. The figure is the account's unspent balance on 09/10/2024, not an encumbrance. The same report's unspent figure, 145,506.42 (p1), equals 148,677.02 received less the 3,170.60 expended, so it counts the same 17,002.43 as uncommitted. The report prints the received total as 14,8677.02. The FY2023 and FY2024 receipts, 59,958.66 and 88,718.36, sum to 148,677.02.